In parallel, epigallocatechin gallate derivative Y6 (EGCG Y6) chokes HCC angiogenesis through MAPK/ERK/2 and PI3K/AKT/HIF-1α/VEGF [14]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.